VIA
AGIO icon

Virtus Investment Advisers’s Agios Pharmaceuticals AGIO Stock Holding History

Virtus Investment Advisers’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
39,473
+8,514
+28% +$258K 0.34% 123
2026
Q1 		$1.05M Buy
30,959
+5,899
+24% +$167K 0.29% 138
2025
Q4 		$682K Buy
25,060
+12,179
+95% +$427K 0.19% 183
2025
Q3 		$517K Hold
12,881
– – 0.15% 202
2025
Q2 		$428K Buy
12,881
+3,473
+37% +$105K 0.14% 213
2025
Q1 		$276K Buy
+9,408
New +$312K 0.07% 247

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Virtus Investment Advisers's AGIO Position: Q2 2026 in Review

Virtus Investment Advisers increased its Agios Pharmaceuticals (AGIO) stake by 28% in Q2 2026, buying an estimated $258K and bringing the position to 39,473 shares worth $1.46M. The position accounts for 0.34% of the portfolio, ranked #123.

Virtus Investment Advisers first reported a position in AGIO in Q1 2025 and has held it in 6 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Virtus Investment Advisers held 39,473 shares of Agios Pharmaceuticals worth $1.46M as of Q2 2026.
  • Virtus Investment Advisers bought 8,514 Agios Pharmaceuticals shares in Q2 2026, an estimated $258K.
  • Agios Pharmaceuticals made up 0.34% of Virtus Investment Advisers's portfolio in Q2 2026, its #123 holding.
  • Virtus Investment Advisers first reported a position in Agios Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.